The article provides an overview of recent developments in the healthcare sector, including Novo Nordisk's phase-out of ...
Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...
From wearable glucose monitors to AI-driven health insights, recent advances are giving patients new ways to manage blood ...
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...
Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...
The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback